1. Home
  2. BPRN vs ALLO Comparison

BPRN vs ALLO Comparison

Compare BPRN & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPRN
  • ALLO
  • Stock Information
  • Founded
  • BPRN 2007
  • ALLO 2017
  • Country
  • BPRN United States
  • ALLO United States
  • Employees
  • BPRN N/A
  • ALLO N/A
  • Industry
  • BPRN Major Banks
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BPRN Finance
  • ALLO Health Care
  • Exchange
  • BPRN Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • BPRN 207.5M
  • ALLO 252.9M
  • IPO Year
  • BPRN N/A
  • ALLO 2018
  • Fundamental
  • Price
  • BPRN $32.28
  • ALLO $1.23
  • Analyst Decision
  • BPRN Strong Buy
  • ALLO Buy
  • Analyst Count
  • BPRN 1
  • ALLO 11
  • Target Price
  • BPRN $35.00
  • ALLO $8.67
  • AVG Volume (30 Days)
  • BPRN 10.5K
  • ALLO 2.3M
  • Earning Date
  • BPRN 10-29-2025
  • ALLO 11-06-2025
  • Dividend Yield
  • BPRN 4.19%
  • ALLO N/A
  • EPS Growth
  • BPRN 62.30
  • ALLO N/A
  • EPS
  • BPRN 2.57
  • ALLO N/A
  • Revenue
  • BPRN $76,577,000.00
  • ALLO N/A
  • Revenue This Year
  • BPRN $14.10
  • ALLO N/A
  • Revenue Next Year
  • BPRN $8.94
  • ALLO $100.00
  • P/E Ratio
  • BPRN $12.99
  • ALLO N/A
  • Revenue Growth
  • BPRN 13.94
  • ALLO N/A
  • 52 Week Low
  • BPRN $27.25
  • ALLO $0.86
  • 52 Week High
  • BPRN $38.78
  • ALLO $3.78
  • Technical
  • Relative Strength Index (RSI)
  • BPRN 51.65
  • ALLO 51.73
  • Support Level
  • BPRN $32.58
  • ALLO $1.16
  • Resistance Level
  • BPRN $33.50
  • ALLO $1.28
  • Average True Range (ATR)
  • BPRN 0.75
  • ALLO 0.08
  • MACD
  • BPRN 0.11
  • ALLO 0.01
  • Stochastic Oscillator
  • BPRN 57.40
  • ALLO 79.17

About BPRN Princeton Bancorp Inc. (PA)

Princeton Bancorp Inc is a banking company. It is a full-service financial institution that provides business and personal banking. Its personal banking and business banking services include checking accounts and savings accounts. It offers traditional retail banking services, one-to-four-family residential mortgage loans, multi-family and commercial mortgage loans, construction loans, commercial business loans, and consumer loans, including home equity loans and lines of credit. The Bank also has two retail branches and conducts loan origination activities in select areas of the New York City metropolitan area.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: